Login / Signup

A phase I clinical trial to evaluate the safety of HU-045 for treating moderate-to-severe glabellar lines: a pilot study.

Hye Sung HanJ W ParkKwang Ho YooB J Kim
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
Keyphrases
  • clinical trial
  • high intensity
  • phase ii
  • early onset
  • open label
  • study protocol
  • double blind
  • phase iii
  • randomized controlled trial